Ayurcann Holdings 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Igal Sudman

최고 경영자

CA$986.4k

총 보상

CEO 급여 비율	23.4%
CEO 임기	3.7yrs
CEO 소유권	23.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	3.5yrs

최근 관리 업데이트

Recent updates

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Jun 28

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

May 11

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Mar 22

CEO 보상 분석

Igal Sudman 의 보수는 Ayurcann Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	-CA$4m
Mar 31 2024	n/a	n/a	-CA$4m
Dec 31 2023	n/a	n/a	-CA$5m
Sep 30 2023	n/a	n/a	-CA$5m
Jun 30 2023	CA$986k	CA$230k	-CA$5m
Mar 31 2023	n/a	n/a	-CA$5m
Dec 31 2022	n/a	n/a	-CA$4m
Sep 30 2022	n/a	n/a	-CA$4m
Jun 30 2022	CA$188k	CA$188k	-CA$3m
Mar 31 2022	n/a	n/a	CA$401k
Dec 31 2021	n/a	n/a	CA$61k
Sep 30 2021	n/a	n/a	CA$61k
Jun 30 2021	CA$120k	CA$120k	-CA$278k

보상 대 시장: Igal 의 총 보상 ($USD 706.15K )은 Canadian 시장( $USD 169.25K ).

보상과 수익: 회사가 수익성이 없는 동안 Igal 의 보상이 증가했습니다.

CEO

Igal Sudman

3.7yrs

테뉴어

CA$986,370

보상

Mr. Igal Sudman serves as Chairman, Corporate Secretary & CEO of Ayurcann Holdings Corp. He is a Co-Founder of Ayurcann Holdings Corp. Mr. Sudman serves as Director of Ayurcann Holdings Corp. since March 2...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Igal Sudman	Co-Founder	3.7yrs	CA$986.37k	23.13% CA$ 1.6m
Buzaker Roman	Co-Founder	3.7yrs	CA$984.29k	22.98% CA$ 1.6m
David Hackett	Independent Director	3.7yrs	CA$68.00k	0.66% CA$ 45.2k
Iris Bincovich	Member of Advisory Board	3.5yrs	데이터 없음	데이터 없음
Alison Gordon	Independent Director	3.7yrs	CA$60.00k	0.60% CA$ 40.6k
Michael Ash	Member of Advisory Board	3.5yrs	데이터 없음	데이터 없음
Trina Fraser	Member of Advisory Board	3.5yrs	데이터 없음	데이터 없음
Maor Shayit	Independent Director	3.7yrs	CA$60.00k	0.60% CA$ 40.6k
Barry Katzman	Member of Advisory Board	3.5yrs	데이터 없음	데이터 없음
Casey Hiltemann	Member of Advisory Board	3.5yrs	데이터 없음	데이터 없음
Benjamin Feferman	Member of Advisory Board	3.5yrs	데이터 없음	데이터 없음

3.5yrs

평균 재임 기간

경험이 풍부한 이사회: AYUR 의 이사회는 경험(평균 재직 기간 3.5 년)으로 간주됩니다.

Ayurcann Holdings 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

High number of new and inexperienced directors

Recent updates

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) cancelled the acquisition of Ayurcann Holdings Corp. (CNSX:AYUR).

Full year 2024 earnings released: CA$0.022 loss per share (vs CA$0.035 loss in FY 2023)

Arogo Capital Acquisition Corp. (NasdaqGM:AOGO) entered into a definitive business combination agreement to acquire Ayurcann Holdings Corp. (CNSX:AYUR).

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.007 loss in 3Q 2023)

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Second quarter 2024 earnings released: CA$0.005 loss per share (vs CA$0.001 loss in 2Q 2023)

First quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.007 loss in 1Q 2023)

Ayurcann Holdings Corp., Annual General Meeting, Dec 20, 2023

Full year 2023 earnings released: CA$0.035 loss per share (vs CA$0.026 loss in FY 2022)

Ayurcann Holdings Corp. Provides Corporate Update

Third quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2022)

Second quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.007 loss per share (vs CA$0.001 profit in 1Q 2022)

High number of new and inexperienced directors

Ayurcann Holdings Corp., Annual General Meeting, Dec 21, 2022

Full year 2022 earnings released: CA$0.026 loss per share (vs CA$0.003 loss in FY 2021)

Ayurcann Holdings Corp. Expands Product Offerings Across Canada

Ayurcann Holdings Corp. (CNSX:AYUR) completed the acquisition of Joints and Hustle & Shake Inc. from Tetra Oils Inc. for CAD 3.6 million.

Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.011 loss in 3Q 2021)

High number of new and inexperienced directors

Ayurcann Holdings Corp. Receives Flower Sales Licence from Health Canada

Ayurcann Holdings Corp. (CNSX:AYUR) signed a letter of intent to acquire 100% interest in Joints and Hustle & Shake Inc. from Tetra Oils Inc.

Consensus forecasts updated

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: CA$0.003 loss per share (vs CA$0.008 loss in FY 2020)

Ayurcann Holdings Corp. announced that it has received CAD 0.602832 million in funding

Ayurcann Holdings Corp. announced that it expects to receive CAD 0.5 million in funding

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간